Medicine News

• FDA Takes New Regulatory Action Against Ranbaxy's Paonta Sahib Plant In India
  Sat, 28 February 2009
  The U.S. Food and Drug Administration announced that a facility owned by India-based Ranbaxy Laboratories falsified data and test results in approved and pending drug applications. The facility, Paonta Sahib, has been under an FDA Import Alert since September 2008. The FDA is continuing to investigate this matter to ensure ...
• Probing And Controlling 'Molecular Rattling' May Mean Better Preservatives
  Sat, 28 February 2009
  For centuries, people have preserved fruit by mixing it with sugar, making thick jams that last for months without spoiling. Now scientists at the National Institute of Standards and Technology (NIST) have discovered a fundamental property of mixture behavior that might help extend the life of many things including vaccines, ...
• Consumer Medication Information Falls Short, University Of Florida Researchers Say
  Sat, 28 February 2009
  Two University of Florida pharmacy faculty members will tell a U.S. Food and Drug Administration panel this week that the information that accompanies prescription medicine often does not follow FDA format and content recommendations. Consumers should be able to easily recognize essential information in the drug handouts ...
• Justice Department Files Suit Against Forest Laboratories For Illegally Marketing Celexa ...
  Sat, 28 February 2009
  The U.S. Department of Justice on Wednesday filed a civil complaint against drugmaker Forest Laboratories alleging the company defrauded the government of millions of dollars by illegally marketing antidepressants Celexa and Lexapro for use in children, the New York Times reports.
• WHO Approves Heat-Stable, Generic Version Of Abbott's Kaletra
  Sat, 28 February 2009
  The pharmaceutical company Mylan on Wednesday announced that the World Health Organization has approved its heat-stable, generic version of Abbott Laboratories' antiretroviral drug Kaletra, the AP/MSNBC reports.
• Cerimon Pharmaceuticals Initiates Phase III Clinical Studies To Evaluate Its Topical Dic ...
  Fri, 27 February 2009
  Cerimon Pharmaceuticals, Inc., announced the Company has enrolled its first subjects in its once-daily topical diclofenac sodium patch Phase III program. The program consists of three randomized, double-blind, placebo-controlled Phase III clinical studies with Cerimon's diclofenac patch.
• Poniard Pharmaceuticals Announces New Efficacy And Safety Data From A Phase 2 Picoplatin ...
  Fri, 27 February 2009
  Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of new efficacy and safety data from its ongoing Phase 2 clinical trial of picoplatin in combination with docetaxel and prednisone as first-line therapy for metastatic castration-res ...
• Comprehensive Health Reform: A Must Pass This Year
  Fri, 27 February 2009
  Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement regarding President Obama's address to a joint session of Congress last night: PhRMA applauds President Obama for making clear that comprehensive healthcare reform is a top priority for his ad ...
• Annual Event For Entrepreneurs In Biotech, Pharma And Healthcare - France
  Fri, 27 February 2009
  Profession Bio-Entrepreneur, France's annual event for entrepreneurs in biotech, pharma and healthcare will take place this year on Thursday and Friday 12-13 March. It is organized by Centrale-SantÃ, part of the association of the Ecole Centrale, one of France's top graduate schools in partnership with MEDEC, France's annua ...
• Medtronic Announces Plans To Begin To Disclose Payments To Physicians In 2011
  Fri, 27 February 2009
  Medtronic on Tuesday announced plans to begin to disclose certain payments to physicians, the AP/Miami Herald reports. In a statement, Medtronic said that the company will begin to collect information on payments to physicians and make the first disclosures in March 2011 (AP/Miami Herald, 2/24).